Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

Similar articles for PubMed (Select 16539746)

2.

Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.

Hu WX, Zeng ZJ, Luo SQ, Chen Q.

Chin Med J (Engl). 2004 Mar;117(3):434-9.

PMID:
15043787
3.

[The construction of recombinant AAV vector expressing HSVtk gene controlled by Tet-On and the detection of its activity].

Chen Q, Li ZB, Zeng ZJ, Luo SQ, Hu WX.

Sheng Wu Gong Cheng Xue Bao. 2005 May;21(3):360-4. Chinese.

PMID:
16108356
4.
5.

Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.

Tang Q, Zhang D, Wan M, Jin L.

Cancer Biother Radiopharm. 2007 Dec;22(6):755-61.

PMID:
18158766
7.

Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.

Kanazawa T, Mizukami H, Okada T, Hanazono Y, Kume A, Nishino H, Takeuchi K, Kitamura K, Ichimura K, Ozawa K.

Gene Ther. 2003 Jan;10(1):51-8.

PMID:
12525837
8.

Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.

Anderson LM, Swaminathan S, Zackon I, Tajuddin AK, Thimmapaya B, Weitzman SA.

Gene Ther. 1999 May;6(5):854-64.

9.

Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.

Wang ZX, Bian HB, Yang JS, De W, Ji XH.

Cancer Biol Ther. 2009 Aug;8(15):1480-8. Epub 2009 Aug 8.

PMID:
19571664
10.

Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas.

Azatian A, Yu H, Dai W, Schneiders FI, Botelho NK, Lord RV.

J Gastrointest Surg. 2009 Jun;13(6):1044-51. doi: 10.1007/s11605-009-0839-1. Epub 2009 Mar 10.

PMID:
19277794
11.
12.

Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo.

Ardiani A, Sanchez-Bonilla M, Black ME.

Cancer Gene Ther. 2010 Feb;17(2):86-96. doi: 10.1038/cgt.2009.60. Epub 2009 Sep 18.

13.

The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells.

Zeng ZJ, Xiang SG, Xue WW, Li HD, Ma N, Ren ZJ, Xu ZJ, Jiao CH, Wang CY, Hu WX.

Biomed Pharmacother. 2014 Sep;68(7):887-92. doi: 10.1016/j.biopha.2014.07.018. Epub 2014 Jul 28.

PMID:
25217394
14.

Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.

Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD.

Gene Ther. 2006 Feb;13(3):206-15.

PMID:
16307003
15.

In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.

J Gene Med. 2004 Mar;6(3):288-99.

PMID:
15026990
16.

Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.

Kuriyama S, Masui K, Kikukawa M, Sakamoto T, Nakatani T, Nagao S, Yamazaki M, Yoshiji H, Tsujinoue H, Fukui H, Yoshimatsu T, Ikenaka K.

Gene Ther. 1999 Apr;6(4):525-33.

17.

Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.

Zhang JH, Wan MX, Pan BR, Yu B.

Cancer Biol Ther. 2004 Nov;3(11):1075-80. Epub 2004 Nov 12.

PMID:
15477756
18.

Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound.

Aoi A, Watanabe Y, Mori S, Takahashi M, Vassaux G, Kodama T.

Ultrasound Med Biol. 2008 Mar;34(3):425-34. Epub 2007 Dec 21.

PMID:
18096302
19.

[DNA damage caused by suicide gene therapy system under Tet-On regulation in breast cancer cells].

Li H, Xiang S, Ma N, Hu W, Zeng Z.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Sep;36(9):836-43. doi: 10.3969/j.issn.1672-7347.2011.09.004. Chinese.

20.

Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.

Castillo-Rodríguez RA, Arango-Rodríguez ML, Escobedo L, Hernandez-Baltazar D, Gompel A, Forgez P, Martínez-Fong D.

PLoS One. 2014 May 13;9(5):e97151. doi: 10.1371/journal.pone.0097151. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk